David Campbell
Amministratore Delegato presso JANUX THERAPEUTICS, INC.
Patrimonio netto: 16 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di David Campbell
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection. The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force.
23
| Extinct | Pharmaceuticals: Major | 23 |
Public Company | Biotechnology | 19 | |
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA.
1
| Subsidiary | Biotechnology | 1 |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David Campbell tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Stanford University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree | |
SYNTHORX, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer Director of Finance/CFO | |
San Diego State University | College/University | Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Founder Director of Finance/CFO Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Chief Executive Officer Director/Board Member Director/Board Member | |
Antipodean Pharmaceuticals, Inc.
Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree Director/Board Member Undergraduate Degree | |
AMBRX INC | Pharmaceuticals: Major | Founder Chairman Director/Board Member | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Nerio Therapeutics, Inc.
Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Panorama Capital LLC
Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Investment Managers | Founder Chief Investment Officer Private Equity Analyst | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Chairman | |
SEQUENOM, INC. | Medical Specialties | Corporate Officer/Principal Comptroller/Controller/Auditor | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Founder Corporate Officer/Principal | |
ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
XENOPORT, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Georgetown University | College/University | Director/Board Member Undergraduate Degree | |
University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
TURG POIN | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
Wake Forest University | College/University | Doctorate Degree Undergraduate Degree | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Doctorate Degree Doctorate Degree | |
UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
DJO Global, Inc.
DJO Global, Inc. Medical SpecialtiesHealth Technology DJO Global, Inc. engages in the development and distribution medical devices for musculoskeletal health, joint reconstruction, vascular health, and pain management. Its product include knee ligament bracing, custom bracing, post-op knee bracing, hip implants, shoulder implants, shoulder bracing, spine bracing, cervical collars, walking braces, and ankle bracing. The company was founded by Mark Nordquist and Ken Reed in 1978 and is headquartered in Lewisville, TX. | Medical Specialties | Director of Finance/CFO Comptroller/Controller/Auditor | |
University of California, Davis | College/University | Graduate Degree Undergraduate Degree | |
OTONOMY | Biotechnology | Director/Board Member Chief Executive Officer | |
Avalon Ventures Management LLC
Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | Investment Managers | Private Equity Investor Director of Finance/CFO | |
Washington University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
University of California, Berkeley | College/University | Corporate Officer/Principal Doctorate Degree | |
Afraxis, Inc.
Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Biotechnology | Chief Executive Officer Founder | |
The University of Chicago | College/University | Masters Business Admin Undergraduate Degree | |
Rice University | College/University | Undergraduate Degree Undergraduate Degree | |
Cellular Approaches, Inc.
Cellular Approaches, Inc. BiotechnologyHealth Technology Cellular Approaches, Inc. operates in the biotechnology industry. It develops pipeline of innate immunity cell-based therapeutics for the treatment of infectious disease, autoimmunity, neurodegeneration and aging. The company was founded in 2016 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
AristaMD, Inc.
AristaMD, Inc. Internet Software/ServicesTechnology Services AristaMD, Inc. develops specialty care platform and seamlessly integrate into clinical workflows. It provides eConsult solutions to empower primary care providers with clinical workup checklists and the ability to conduct electronic consults. The company was founded by Rebecca Cofinas in 2014 and is headquartered in La Jolla, CA. | Internet Software/Services | Chief Executive Officer Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 49 |
Australia | 2 |
Nuova-Zelanda | 2 |
Settori
Health Technology | 25 |
Consumer Services | 17 |
Finance | 6 |
Commercial Services | 4 |
Health Services | 2 |
Posizioni
Director/Board Member | 299 |
Corporate Officer/Principal | 123 |
Independent Dir/Board Member | 82 |
Chairman | 40 |
Chief Executive Officer | 40 |
Contatti più connessi
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
Daniel Janney | 47 |
Peter Thompson | 39 |
Jay Lichter | 38 |
Deepa Pakianathan | 32 |
Julie Cherrington | 32 |
John D. Diekman | 29 |
Vickie Capps | 27 |
Peter G. Schultz | 21 |
Laura Shawver | 18 |
Sheila Gujrathi | 18 |
D. W. E. Wicker | 16 |
Nancy Hong | 14 |
Tighe Reardon | 14 |
Girish Putcha | 14 |
- Borsa valori
- Insiders
- David Campbell
- Connessioni Società